时间：2026年6月29日
Date: June 29, 2026
罗氏推出搭载革命性SBX技术的AXELIOS 1新一代测序平台
Roche Launches AXELIOS 1 Next-Generation Sequencing Platform with Revolutionary SBX Technology
摘要 :
该平台最长支持约1500bp读长，兼具高准确度、高速度、高灵活性与成本效益优势。罗氏已与哈特维格医学基金会、博德临床实验室、10x Genomics、谷歌DeepVariant等机构达成合作，并推出开源生物信息学分析套件XOOS。当前全球测序市场规模达73亿美元，预计未来数年将维持两位数增速。
Summary :
The platform supports read lengths of up to approximately 1,500bp, combining high accuracy, high speed, high flexibility, and cost-effectiveness. Roche has established partnerships with Hartwig Medical Foundation, Bode Clinical Laboratory, 10x Genomics, Google DeepVariant, and others, while launching the open-source bioinformatics analysis suite XOOS. The current global sequencing market is valued at USD 7.3 billion, expected to maintain double-digit growth in coming years.
入选理由 :
生命科学领域的重大突破。AXELIOS 1创下全球最快DNA测序世界纪录，代表精准医疗、基因技术、AI辅助研发三大前沿领域的范式转变。罗氏作为全球制药行业龙头，此次切入基因测序赛道展现其从药物向诊断全面布局的战略意图。
Why Selected:
A major breakthrough in life sciences. AXELIOS 1 sets the world record for the fastest DNA sequencing, representing a paradigm shift in precision medicine, gene technology, and AI-assisted research. As the global pharmaceutical leader, Roche is making a strategic move into gene sequencing, demonstrating its comprehensive layout from drugs to diagnostics.
浏览量：72,000+
Views：72,000+
独立IP：48,000+
Unique Clicks ：48,000+
